NDC codes

FDA NDC Directory
Product NDC (as listed)42291-477Labeler and product segments. Claims need a package NDC.
Product NDC at billing width42291-0477Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
42291-477-304229104773030 POUCH in 1 BOX (42291-477-30) / 1 PATCH in 1 POUCH (42291-477-11)Marketed from Nov 16, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Lidocaine
Generic name (nonproprietary)
lidocaine
Active ingredients
Lidocaine — 700 mg/1
Dosage form
Patch
Route
Topical
Labeler
AvKARE
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 206463
Marketing start
Listing expires
Other FDA classes
Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers
Product ID 42291-477_485f641e-e708-998d-e063-6394a90adcd9SPL ID 485f641e-e708-998d-e063-6394a90adcd9SPL set ID 0a4cc4f8-9c5d-d03f-e063-6394a90a1b2eRxCUI 1745091UNII 98PI200987
Pharmacologic class
Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442291047730 followed by a unit qualifier and the quantity

Package 42291-0477-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATION AND USAGE Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206463

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206463
ProductStrengthForm · routeLabelerProduct NDC
LidocaineLidocaine 700 mg/1PatchTopicalASCLEMED USA INC.87063-273
Lidocaine PatchLidocaine 700 mg/1PatchTopicalDirect_Rx72189-387
LidocaineLidocaine 700 mg/1PatchTopicalA-S Medication Solutions50090-7894
LidocaineLidocaine 700 mg/1PatchTopicalPHOENIX RX LLC85509-1791
LidocaineLidocaine 700 mg/1PatchTopicalAmneal Pharmaceuticals LLC65162-791
LidocaineLidocaine 700 mg/1PatchTopicalAdvanced Rx Pharmacy of Tennessee, LLC80425-0325
LidocaineLidocaine 700 mg/1PatchTopicalPreferred Pharmaceuticals Inc.68788-8344
LidocaineLidocaine 700 mg/1PatchTopicalSportpharm LLC85766-170
LidocaineLidocaine 700 mg/1PatchTopicalBryant Ranch Prepack71335-1971
LidocaineLidocaine 700 mg/1PatchTopicalBryant Ranch Prepack72162-2085

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in